BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 38443283)

  • 1. Effects of low fat diet on inflammatory parameters in individuals with obesity/overweight and non-alcoholic fatty liver disease: A cross-sectional study.
    Erdem NB; Kahramanoğlu Aksoy E; Dikmen D; Uçar Baş K; Ağaçdiken A; İlhan Esgin M; Göktaş Z
    Medicine (Baltimore); 2024 Apr; 103(15):e37716. PubMed ID: 38608067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waist Circumference Change During Intensive Lifestyle Intervention and Cardiovascular Morbidity and Mortality in the Look AHEAD Trial.
    Olson KL; Neiberg RH; Espeland MA; Johnson KC; Knowler WC; Pi-Sunyer X; Staiano AE; Wagenknecht LE; Wing RR;
    Obesity (Silver Spring); 2020 Oct; 28(10):1902-1911. PubMed ID: 32881403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models.
    Stewart KE; Haller DL; Sargeant C; Levenson JL; Puri P; Sanyal AJ
    Liver Int; 2015 Mar; 35(3):936-43. PubMed ID: 24521540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biobehavioral and psychological differences between overweight adults with and without waist circumference risk.
    Grossniklaus DA; Gary RA; Higgins MK; Dunbar SB
    Res Nurs Health; 2010 Dec; 33(6):539-51. PubMed ID: 21053387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight change and cognitive function: findings from the Women's Health Initiative Study of Cognitive Aging.
    Driscoll I; Espeland MA; Wassertheil-Smoller S; Gaussoin SA; Ding J; Granek IA; Ockene JK; Phillips LS; Yaffe K; Resnick SM;
    Obesity (Silver Spring); 2011 Aug; 19(8):1595-600. PubMed ID: 21394095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
    Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
    Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Metabolic Phenotypes of Body Fatness and Incident Stroke: A Prospective Cohort Study of Chinese Community Residents.
    Tang M; Zhao Q; Yi K; Wu Y; Xiang Y; Zaid M; Cui S; Su X; Yu Y; Zhao G; Jiang Y
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolically unhealthy obesity, overweight, and normal weight and the associated risk factors in a southern coastal region, Iran (the PERSIAN cohort study): a cross-sectional study.
    Zoghi G; Shahbazi R; Mahmoodi M; Nejatizadeh A; Kheirandish M
    BMC Public Health; 2021 Nov; 21(1):2011. PubMed ID: 34740348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
    Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
    Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between weight change, waist circumference change, and the risk of nonalcoholic fatty liver disease in individuals with metabolically healthy overweight or obesity and metabolically unhealthy overweight or obesity.
    Man S; Deng Y; Ma Y; Yang X; Wang X; Fu J; Yu C; Lv J; Du J; Wang B; Li L
    Obes Res Clin Pract; 2024; 18(2):109-117. PubMed ID: 38443283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
    Lonardo A; Mantovani A; Lugari S; Targher G
    Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.